High-risk HPV screening - A retrospective study of a Portuguese cervical cancer screening program

被引：0
|
作者：
Moiteiro da Cruz, R. [1 ,2 ]
Andre Sousa Oliveira, T.
Boavida, J.
Pinho, M.
Ferreira, C.
Lopez-Presa, D.
机构：
[1] CHULN, Hosp Santa Maria, Dept Pathol, Lisbon, Portugal
[2] Univ Lisbon, Fac Med, Lisbon, Portugal
来源：
VIRCHOWS ARCHIV | 2022年 / 481卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-08-034
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [1] Triage of high-risk HPV positive women in cervical cancer screening
    Ebisch, Renee M. F.
    Siebers, Albert G.
    Bosgraaf, Remko P.
    Massuger, Leon F. A. G.
    Bekkers, Ruud L. M.
    Melchers, Willem J. G.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (10) : 1073 - 1085
  • [2] Screening for cervical cancer: Should we test for infection with high-risk HPV?
    Meijer, CJLM
    Snijders, PJF
    van den Brule, AJC
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2000, 163 (05) : 535 - 538
  • [3] Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
    Wei, Baojun
    Mei, Ping
    Huang, Shengkai
    Yu, Xueting
    Zhi, Tong
    Wang, Guojing
    Xu, Xiaotian
    Xiao, Lin
    Dong, Xin
    Cui, Wei
    VIROLOGY JOURNAL, 2020, 17 (01)
  • [4] Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
    Baojun Wei
    Ping Mei
    Shengkai Huang
    Xueting Yu
    Tong Zhi
    Guojing Wang
    Xiaotian Xu
    Lin Xiao
    Xin Dong
    Wei Cui
    Virology Journal, 17
  • [5] HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
    Kares, Saara
    Veijalainen, Olga
    Kholova, Ivana
    Tirkkonen, Mika
    Vuento, Risto
    Huhtala, Heini
    Tuimala, Veronica
    Maenpaa, Johanna
    Kujala, Paula
    APMIS, 2019, 127 (11) : 710 - 716
  • [6] Validation of high-risk HPV tests for primary cervical screening
    Meijer, C. J. L. M.
    Berkhof, H.
    Heideman, D. A. M.
    Hesselink, A. T.
    Snijders, P. J. F.
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S1 - S4
  • [7] Physicians' perception of the ability of primary high-risk HPV screening to detect cervical cancer: A survey study
    Hodeib, Melissa
    Hahn, Erin E.
    Mittman, Brian S.
    Cannizzaro, Nancy
    Xu, Lanfang
    Metzger, Quyen
    Tewari, Devansu
    Chao, Chun Rebecca
    GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : E24 - E25
  • [8] Primary high-risk HPV screening for cervical cancer in post-menopausal women
    Gyllensten, Ulf
    Gustaysson, Inger
    Lindell, Monica
    Wilander, Erik
    GYNECOLOGIC ONCOLOGY, 2012, 125 (02) : 343 - 345
  • [9] High-Risk HPV Screening Initiative in Kosovo-A Way to Optimize HPV Vaccination for Cervical Cancer
    Bentz, Jessica L.
    Barney, Rachael E.
    Georgantzoglou, Natalia
    Manxhuka-Kerliu, Suzana
    Ibishi, Vlora Ademi
    Dacaj-Elshani, Brikene
    Bejarano, Suyapa
    Palumbo, Paul E.
    Suresh, Arvind
    LaRochelle, Ethan P. M.
    Keegan, William P.
    Wilson, Teresa L.
    Dokus, Betty J.
    Hershberger, Kenneth C.
    Gallagher, Torrey L.
    Allen, Samantha F.
    Palisoul, Scott M.
    Steinmetz, Heather B.
    Kennedy, Linda S.
    Tsongalis, Gregory J.
    DISEASES, 2024, 12 (08)
  • [10] Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa
    Vijayaraghavan, Arthi
    Efrusy, Molly
    Lindeque, Gerhard
    Dreyer, Greta
    Santas, Christopher
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : 377 - 383
12345